Fundz Deep Dive
Everything you need to win Agilent Technologies — in one platform.
Who to reach, what to say, and why now on Agilent Technologies — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Agilent Technologies — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Contract Type
agreement
Santa ClaraBiotechnologyLife ScienceHealth DiagnosticsDescription
Agilent Technologies Inc. (NYSE: A) has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing organization based in Canada that produces biologics, highly potent active pharmaceutical ingredients, and other molecules for targeted therapeutics.
Related People
Suggested for you
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months